Antiverse is dedicated to engineering the future of drug development to change the course of people's lives.
Antiverse is a new type of antibody discovery company accelerating drug development. Its platform exists at the intersection of structural biology, machine learning, and medicine to enable breakthroughs to happen more quickly and cost-effectively. It is dedicated to engineering the future of drug development to change the course of people's lives.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jul 12, 2018 | Grant | £20K | 1 | Accelerate@Babraham | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Accelerate@Babraham | Yes | Grant |